Biosimilars Pathway In WHO Draft Guidance Drops Dual-track Approach
Executive Summary
A World Health Organization working group dropped the less rigorous of two approaches for regulating biosimilars from its latest draft guidelines, a positive step, according to generic drug maker Sandoz